- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DaVita HealthCare Partners Inc (DVA)
DaVita HealthCare Partners Inc stock price live, this page displays NYSE DVA stock exchange data. View the DVA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the DaVita HealthCare Partners Inc real time stock price chart below.
What Is the DaVita HealthCare Partners Inc Stock Price Today?
The DaVita HealthCare Partners Inc stock price today is 140.03.
What Is the Stock Symbol for DaVita HealthCare Partners Inc?
The stock ticker symbol for DaVita HealthCare Partners Inc is DVA.
Is DVA the Same as $DVA?
$DVA is a common way to refer to the DaVita HealthCare Partners Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does DaVita HealthCare Partners Inc Trade On?
DaVita HealthCare Partners Inc is listed and trades on the NYSE stock exchange.
Is DaVita HealthCare Partners Inc a Good Stock to Buy?
Determining whether DaVita HealthCare Partners Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current DaVita HealthCare Partners Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DVA quote. (ISIN: US23918K1088)
What Is the DaVita HealthCare Partners Inc Stock Price Today?
The DaVita HealthCare Partners Inc stock price today is 140.03.
What Is the Stock Symbol for DaVita HealthCare Partners Inc?
The stock ticker symbol for DaVita HealthCare Partners Inc is DVA.
Is DVA the Same as $DVA?
$DVA is a common way to refer to the DaVita HealthCare Partners Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does DaVita HealthCare Partners Inc Trade On?
DaVita HealthCare Partners Inc is listed and trades on the NYSE stock exchange.
Is DaVita HealthCare Partners Inc a Good Stock to Buy?
Determining whether DaVita HealthCare Partners Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current DaVita HealthCare Partners Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DVA quote. (ISIN: US23918K1088)
140.03
-1.47(-1.04%)
Closed·
After Hours
141.74+1.71(+1.22%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
136.54
141.59
52 wk Range
128.69
179.60
DVA Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
136.54141.59
52 wk Range
128.69179.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DVA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
164.57
Upside
+17.52%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
DaVita HealthCare Partners Inc Company Profile
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
DaVita HealthCare Partners Inc SWOT Analysis
Analyst Outlook | With an average price target of $161, analysts anticipate DaVita's strategic advantages and operational efficiency to drive future growth and profitability |
Policy Tailwinds | Explore how recent ESRD rate revisions and phosphate binder reimbursement changes could boost DaVita's revenue by $50-100 million, potentially increasing EPS |
Financial Resilience | Despite headwinds, DaVita maintains robust financial health with a P/E ratio of 12.92 and an impressive free cash flow yield of 13%, signaling potential value |
Kidney Care Dominance | DaVita's market leadership in kidney care services, bolstered by its vast network of dialysis centers, positions it strongly in the face of industry challenges |
DaVita HealthCare Partners Inc Earnings Call Summary for Q3/2024
- DaVita maintains 2024 guidance: $1.91-$2.01B adjusted operating income, $9.25-$10.05 EPS, despite hurricane impacts
- Q3 results: $535M adjusted operating income, $2.59 EPS; flat treatment volume growth, increased revenue per treatment
- Debt management successful: nearest maturity in 2028, leverage within target; 2.7M shares repurchased in Q3
- Anticipates 50-100 bps treatment growth for full year; preparing for operational adjustments and growth opportunities
- Expects CMS 2025 rule to include oral-only drugs in Medicare Part B; international growth potential highlighted
Last Updated: 10/30/2024, 02:12 PM
Read Full TranscriptCompare DVA to Peers and Sector
Metrics to compare | DVA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDVAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 12.0x | −0.9x | −0.5x | |
PEG Ratio | 0.27 | −0.01 | 0.00 | |
Price / Book | 92.5x | 1.0x | 2.6x | |
Price / LTM Sales | 0.9x | 1.5x | 2.9x | |
Upside (Analyst Target) | 17.8% | 28.4% | 57.8% | |
Fair Value Upside | Unlock | 13.7% | 10.2% | Unlock |
Analyst Ratings
1 Buy
8 Hold
1 Sell
Ratings:
10 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 164.57
(+17.52% Upside)
Earnings
Latest Release
Feb 13, 2025
EPS / Forecast
2.24 / 2.13
Revenue / Forecast
3.30B / 3.26B
People Also Watch
FAQ
What Is the DaVita (DVA) Stock Price Today?
The DaVita stock price today is 140.03
What Stock Exchange Does DaVita Trade On?
DaVita is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for DaVita?
The stock symbol for DaVita is "DVA."
What Is the DaVita Market Cap?
As of today, DaVita market cap is 11.20B.
What is DaVita Earnings Per Share?
The DaVita EPS is 11.02.
What Is the Next DaVita Earnings Date?
DaVita will release its next earnings report on May 13, 2025.
From a Technical Analysis Perspective, Is DVA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.